Document:

Exhibit 10.1

 

ASSEMBLY
BIOSCIENCES, INC.

 

2017 Inducement
Award PLAN

 

1.            Purposes
of the Plan. The purposes of this Plan are to attract and retain the best available personnel, to provide an inducement material
for such persons to enter into employment with the Company or a Related Party within the meaning of Rule 5635(c)(4) of the NASDAQ
Listing Rules and to promote the success of the Company’s business.

 

2.            Definitions.
The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual
Award Agreement. In the event a term is separately defined in an individual Award Agreement, such definition shall supersede the
definition contained in this Section 2.

 

(a)          “Administrator”
means the Board or any of the Committees appointed to administer the Plan.

 

(b)          “Affiliate”
and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 promulgated
under the Exchange Act.

 

(c)          “Applicable
Laws” means the legal requirements relating to the Plan and the Awards under applicable provisions of federal and
state securities laws, the corporate laws of California and, to the extent other than California, the corporate law of the state
of the Company’s incorporation, the Code, the rules of any applicable stock exchange or national market system, and the rules
of any non-U.S. jurisdiction applicable to Awards granted to residents therein.

 

(d)          “Assumed”
means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the Company or (ii) the contractual
obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its
Parent in connection with the Corporate Transaction with appropriate adjustments to the number and type of securities of the successor
entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation
element of the Award existing at the time of the Corporate Transaction as determined in accordance with the instruments evidencing
the agreement to assume the Award.

 

(e)          “Award”
means the grant of an Option, SAR, Dividend Equivalent Right, Restricted Stock, Restricted Stock Unit or other right or benefit
under the Plan.

 

(f)          “Award
Agreement” means the written agreement evidencing the grant of an Award executed by the Company and the Grantee,
including any amendments thereto.

 

(g)          “Board”
means the Board of Directors of the Company.

 

     

     

    

 

(h)          “Cause”
means, with respect to the termination by the Company or a Related Entity of the Grantee’s Continuous Service, that such
termination is for “Cause” as such term (or word of like import) is expressly defined in a then-effective written agreement
between the Grantee and the Company or such Related Entity, or in the absence of such then-effective written agreement and definition,
is based on, in the determination of the Administrator, the Grantee’s: (i) performance of any act or failure to perform
any act in bad faith and to the detriment of the Company or a Related Entity; (ii) dishonesty, intentional misconduct or material
breach of any agreement with the Company or a Related Entity; or (iii) commission of a crime involving dishonesty, breach
of trust, or physical or emotional harm to any person; provided, however, that with regard to any agreement that defines “Cause”
on the occurrence of or in connection with a Corporate Transaction, such definition of “Cause” shall not apply until
a Corporate Transaction actually occurs.

 

(i)          “Code”
means the Internal Revenue Code of 1986, as amended, or any successor statute.

 

(j)          “Committee”
means any committee composed of members of the Board appointed by the Board to administer the Plan.

 

(k)          “Common
Stock” means the Company’s Common Stock, par value $0.001 per share.

 

(l)          “Company”
means Assembly Biosciences, Inc., a Delaware corporation, or any successor entity that adopts the Plan in connection with a Corporate
Transaction.

 

(m)          “Continuous
Service” means that the provision of services to the Company or a Related Entity in any capacity of Employee, Director
or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination as an
Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services
to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an
Employee, Director or Consultant can be effective under Applicable Laws. A Grantee’s Continuous Service shall be deemed to
have terminated either upon an actual termination of Continuous Service or upon the entity for which the Grantee provides services
ceasing to be a Related Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave
of absence, (ii) transfers among the Company, any Related Entity, or any successor in any capacity of Employee, Director or
Consultant, or (iii) any change in status as long as the individual remains in the service of the Company or a Related Entity
in any capacity of Employee, Director or Consultant (except as otherwise provided in the Award Agreement). An approved leave of
absence shall include sick leave, military leave, or any other authorized personal leave.

 

(n)          “Corporate
Transaction” means any of the following transactions, provided, however, that the Administrator shall determine under
parts (iv) and (v) whether multiple transactions are related, and its determination shall be final, binding and conclusive:

 

(i)          a
merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which
is to change the state in which the Company is incorporated;

 

    	 	2	 

     

    

 

(ii)         the
sale, transfer or other disposition of all or substantially all of the assets of the Company;

 

(iii)        the
complete liquidation or dissolution of the Company;

 

(iv)        any
reverse merger or series of related transactions culminating in a reverse merger (including, but not limited to, a tender offer
followed by a reverse merger) in which the Company is the surviving entity but (A) the shares of Common Stock outstanding
immediately prior to such merger are converted or exchanged by virtue of the merger into other property, whether in the form of
securities, cash or otherwise, or (B) in which securities possessing more than fifty percent (50%) of the total combined voting
power of the Company’s outstanding securities are transferred to a person or persons different from those who held such securities
immediately prior to such merger or the initial transaction culminating in such merger; or

 

(v)         acquisition
in a single or series of related transactions by any person or related group of persons (other than the Company or by a Company-sponsored
employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing
more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities.

 

(o)          
“Director” means a member of the Board or the board of directors of any Related Entity.

 

(p)          “Disability”
means as defined under the long-term disability policy of the Company or the Related Entity to which the Grantee provides services
regardless of whether the Grantee is covered by such policy. If the Company or the Related Entity to which the Grantee provides
service does not have a long-term disability plan in place, “Disability” means that a Grantee is unable to carry out
the responsibilities and functions of the position held by the Grantee by reason of any medically determinable physical or mental
impairment for a period of not less than ninety (90) consecutive days. A Grantee will not be considered to have incurred a Disability
unless he or she furnishes proof of such impairment sufficient to satisfy the Administrator in its discretion.

 

(q)          “Dividend
Equivalent Right” means a right entitling the Grantee to compensation measured by dividends paid with respect to
Common Stock.

 

(r)          “Employee”
means any person, including an Officer or Director, who is in the employ of the Company or any Related Entity, subject to the control
and direction of the Company or any Related Entity as to both the work to be performed and the manner and method of performance.
The payment of a director’s fee by the Company or a Related Entity shall not be sufficient to constitute “employment”
by the Company.

 

(s)          “Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

(t)          “Fair
Market Value” means, as of any date, the value of Common Stock determined as follows.

 

    	 	3	 

     

    

 

(i)          If
the Common Stock is listed on one or more established stock exchanges or national market systems, including without limitation
The NASDAQ Global Select Market, The NASDAQ Global Market or The NASDAQ Capital Market of The NASDAQ Stock Market LLC, its Fair
Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on the principal
exchange or system on which the Common Stock is listed (as determined by the Administrator) on the date of determination (or, if
no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price
or closing bid was reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable;

 

(ii)         If
the Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities
dealer, its Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such securities dealer
on the date of determination, but if selling prices are not reported, the Fair Market Value of a share of Common Stock shall be
the mean between the high bid and low asked prices for the Common Stock on the date of determination (or, if no such prices were
reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source
as the Administrator deems reliable; or

 

(iii)        In
the absence of an established market for the Common Stock of the type described in (i) and (ii), above, the Fair Market Value thereof
shall be determined by the Administrator in a manner in compliance with Section 409A of the Code.

 

(u)          “Grantee”
means an individual who receives an Award under the Plan.

 

(v)         “Non-Qualified
Stock Option” means an Option not intended to qualify as an incentive stock option within the meaning of Section
422 of the Code.

 

(w)          “Officer”
means a person who is an officer of the Company or a Related Entity within the meaning of Section 16 of the Exchange Act and
the rules and regulations promulgated thereunder.

 

(x)          “Option”
means a Non-Qualified Stock Option to purchase Shares pursuant to an Award Agreement granted under the Plan.

 

(y)          “Parent”
means a “parent corporation,” whether now or hereafter existing, as defined in Section 424(e) of the Code.

 

(z)          “Plan”
means this Assembly Biosciences, Inc. 2017 Inducement Award Plan.

 

(aa)         “Post-Termination
Exercise Period” means the period specified in the Award Agreement of not less than thirty (30) days commencing on
the date of termination (other than termination by the Company or any Related Entity for Cause) of the Grantee’s Continuous
Service, or such longer period as may be applicable upon death or Disability.

 

(bb)        “Related
Entity” means any Parent or Subsidiary of the Company.

 

    	 	4	 

     

    

 

(cc)         “Replaced”
means that pursuant to a Corporate Transaction the Award is replaced with a comparable stock award or a cash incentive program
of the Company, the successor entity (if applicable) or Parent of either of them which preserves the compensation element of such
Award existing at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same (or a more
favorable) vesting schedule applicable to such Award. The determination of Award comparability shall be made by the Administrator
and its determination shall be final, binding and conclusive.

 

(dd)         “Restricted
Stock” means Shares issued under the Plan to the Grantee for such consideration, and subject to such restrictions
on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and conditions as established
by the Administrator.

 

(ee)         “Restricted
Stock Units” means an Award which may be earned in whole or in part upon the passage of time or the attainment of
performance criteria established by the Administrator and which may be settled for cash, Shares or other securities or a combination
of cash, Shares or other securities as established by the Administrator.

 

(ff)         “Rule 16b-3”
means Rule 16b-3 promulgated under the Exchange Act or any successor thereto.

 

(gg)         “SAR”
means a stock appreciation right entitling the Grantee to Shares or cash compensation, as established by the Administrator, measured
by appreciation in the value of Common Stock.

 

(hh)        “Share”
means a share of the Common Stock.

 

(ii)         “Subsidiary”
means a “subsidiary corporation,” whether now or hereafter existing, as defined in Section 424(f) of the Code.

 

3.          Stock
Subject to the Plan.

 

(a)          Subject
to the provisions of Sections 3(b) and 12 below, the maximum aggregate number of Shares which may be issued pursuant to all Awards
is Eight Hundred Thousand (800,000) Shares. The Shares granted under the Plan may be authorized, but unissued, or reacquired Common
Stock.

 

(b)          Any
Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or involuntarily)
shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued
under the Plan. Shares that actually have been issued under the Plan pursuant to an Award shall not be returned to the Plan and
shall not become available for future issuance under the Plan, except that if Options or other Awards granted under this Plan are
forfeited or repurchased by the Company, such Shares shall become available for future grant under the Plan. In the event any Option
or other Award granted under the Plan is exercised through the tendering of shares of Common Stock (either actually or through
attestation), or in the event tax withholding obligations are satisfied by tendering or withholding shares of Common Stock, any
shares of Common Stock so tendered or withheld shall not again be available for awards under the Plan. Shares of Common Stock subject
to an SAR granted pursuant to Section 6(l)of this Plan that are not issued in connection with cash or stock settlement of the exercise
of the SAR shall not again be available for award under the Plan. Shares of Common Stock reacquired by the Company on the open
market or otherwise using cash proceeds from the exercise of Options shall not be available for awards under the Plan.

 

    	 	5	 

     

    

 

4.             Administration
of the Plan.

 

(a)          Plan
Administrator.

 

(i)          Administration
– General. The Plan shall be administered by (A) the Board or (B) a Committee designated by the Board, which
Committee shall be constituted in such a manner as to satisfy the Applicable Laws and to permit such grants and related transactions
under the Plan to be exempt from Section 16(b) of the Exchange Act in accordance with Rule 16b-3. Once appointed, such Committee
shall continue to serve in its designated capacity until otherwise directed by the Board.

 

(ii)         Administration
With in Compliance with Rule 5605(a)(2) of the NASDAQ Listing Rules. Notwithstanding the foregoing or anything in the Plan
to the contrary, the grant of Awards will be approved by the Company’s independent compensation committee or a majority of
the Company’s independent directors (as defined in Rule 5605(a)(2) of the NASDAQ Listing Rules) in order to comply with the
exemption from the stockholder approval requirement for “inducement grants” provided under Rule 5635(c)(4) of the NASDAQ
Listing Rules.

 

(b)          Powers
of the Administrator. Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the Administrator
hereunder), and except as otherwise provided by the Board, the Administrator shall have the authority, in its discretion:

 

(i)          to
select the individuals to whom Awards may be granted from time to time hereunder; provided that Awards may only be granted to individuals
who satisfy the standards for inducement grants under Rule 5635(c)(4) of the NASDAQ Listing Rules;

 

(ii)         to
determine whether and to what extent Awards are granted hereunder;

 

(iii)        to
determine the number of Shares or the amount of other consideration to be covered by each Award granted hereunder;

 

(iv)        to
approve forms of Award Agreements for use under the Plan;

 

(v)         to
determine the type, terms and conditions of any Award granted hereunder;

 

(vi)        to
establish additional terms, conditions, rules or procedures to accommodate the rules or laws of applicable non-U.S. jurisdictions
and to afford Grantees favorable treatment under such rules or laws; provided, however, that no Award shall be granted under any
such additional terms, conditions, rules or procedures with terms or conditions which are inconsistent with the provisions of the
Plan;

 

    	 	6	 

     

    

 

(vii)       to
amend the terms of any outstanding Award granted under the Plan, provided that any amendment that would adversely affect the Grantee’s
rights under an outstanding Award shall not be made without the Grantee’s written consent;

 

(viii)      to
construe and interpret the terms of the Plan and Awards, including without limitation, any notice of award or Award Agreement,
granted pursuant to the Plan;

 

(ix)         to
institute an option exchange program; and

 

(x)          to
take such other action, not inconsistent with the terms of the Plan, as the Administrator deems appropriate.

 

The express grant in the Plan of any specific
power to the Administrator shall not be construed as limiting any power or authority of the Administrator; provided that the Administrator
may not exercise any right or power reserved to the Board. Any decision made, or action taken, by the Administrator or in connection
with the administration of this Plan shall be final, conclusive and binding on all persons having an interest in the Plan.

 

(c)          Indemnification.
In addition to such other rights of indemnification as they may have as members of the Board or as Officers or Employees of the
Company or a Related Entity, members of the Board and any Officers or Employees of the Company or a Related Entity to whom authority
to act for the Board, the Administrator or the Company is delegated shall be defended and indemnified by the Company to the extent
permitted by law on an after-tax basis against all reasonable expenses, including attorneys’ fees, actually and necessarily
incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in connection with any appeal
therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with
the Plan, or any Award granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement
is approved by the Company) or paid by them in satisfaction of a judgment in any such claim, investigation, action, suit or proceeding,
except in relation to matters as to which it shall be adjudged in such claim, investigation, action, suit or proceeding that such
person is liable for gross negligence, bad faith or intentional misconduct; provided, however, that within thirty (30) days after
the institution of such claim, investigation, action, suit or proceeding, such person shall offer to the Company, in writing, the
opportunity at the Company’s expense to defend the same.

 

5.          Eligibility.
Awards may be granted to individuals who become employees of the Company and any Related Entity who satisfy the standards for inducement
grants under Rule 5635(c)(4) of the NASDAQ Listing Rules and where the Award is an inducement material to the individual’s
entering into employment with the Company or a Related Entity. A person who previously served as an Employee or Director will not
be eligible to receive Awards under the Plan, other than following a bona fide period of non-employment. Subject to the foregoing,
Awards may be granted to such individuals who are residing in non-U.S. jurisdictions as the Administrator may determine from time
to time. For clarity, Awards may not be granted to (1) Consultants or Directors for service in such capacity, or (2) any individual
who was previously an Employee or Director, other than following a bona fide period of non-employment. All Awards must be granted
either by a majority of the Company’s independent directors or by the Company’s compensation committee comprised of
independent directors within the meaning of Rule 5605(a)(2) of the NASDAQ Listing Rules.

 

    	 	7	 

     

    

 

6.             Terms
and Conditions of Awards.

 

(a)          Types
of Awards. The Administrator is authorized under the Plan to award any type of arrangement to individuals who become an employee
that is not inconsistent with the provisions of the Plan and that by its terms involves or might involve the issuance of (i) Shares,
(ii) cash or (iii) an Option, an SAR, or similar right with a fixed or variable price related to the Fair Market Value
of the Shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events,
or the satisfaction of performance criteria or other conditions. Such awards include, without limitation, Options, SARs, Restricted
Stock, Restricted Stock Units or Dividend Equivalent Rights, and an Award may consist of one such security or benefit, or two (2) or
more of them in any combination or alternative.

 

(b)          Designation
of Award. Each Award shall be designated in the Award Agreement. In the case of an Option, the Option shall be designated as
a Non-Qualified Stock Option.

 

(c)          Conditions
of Award. Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions of each
Award including, but not limited to, the Award vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions,
form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, and satisfaction of
any performance criteria. The performance criteria established by the Administrator may be based on any one of, or combination
of, increase in share price, earnings per share, total stockholder return, return on equity, return on assets, return on investment,
net operating income, cash flow, revenue, economic value added, initiation or completion of clinical trials, results of clinical
trials, regulatory approval, regulatory submissions, drug development or commercialization milestones, collaboration milestones
or strategic partnerships. Partial achievement of the specified criteria may result in a payment or vesting corresponding to the
degree of achievement as specified in the Award Agreement.

 

(d)          Acquisitions
and Other Transactions. The Administrator may issue Awards under the Plan in settlement, assumption or substitution for, outstanding
awards or obligations to grant future awards in connection with the Company or a Related Entity acquiring another entity, an interest
in another entity or an additional interest in a Related Entity whether by merger, stock purchase, asset purchase or other form
of transaction.

 

(e)          Deferral
of Award Payment. The Administrator may establish one or more programs under the Plan to permit selected Grantees the opportunity
to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that
absent the election would entitle the Grantee to payment or receipt of Shares or other consideration under an Award. The Administrator
may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or
other earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions, rules and procedures
that the Administrator deems advisable for the administration of any such deferral program.

 

    	 	8	 

     

    

 

(f)          Separate
Programs. The Administrator may establish one or more separate programs under the Plan for the purpose of issuing particular
forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to
time.

 

(g)          Early
Exercise. The Award Agreement may, but need not, include a provision whereby the Grantee may elect at any time while an Employee,
Director or Consultant to exercise any part or all of the Award prior to full vesting of the Award. Any unvested Shares received
pursuant to such exercise may be subject to a repurchase right in favor of the Company or a Related Entity or to any other restriction
the Administrator determines to be appropriate.

 

(h)          Term
of Option or SAR. The term of each Option or SAR shall be the term stated in the Award Agreement, provided, however, that the
term shall be no more than ten (10) years from the date of grant thereof.

 

(i)           Transferability
of Awards. Unless the Administrator provides otherwise, in its sole discretion, no Award may be sold, pledged, assigned, hypothecated,
transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during
the lifetime of the Grantee, only by the Grantee. Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries
of the Grantee’s Award in the event of the Grantee’s death on a beneficiary designation form provided by the Administrator.

 

(j)           Time
of Granting Awards. The date of grant of an Award shall for all purposes be the date on which the Administrator makes the determination
to grant such Award, or such other later date as is determined by the Administrator.

 

(k)          Stock
Appreciation Rights. An SAR may be granted (i) with respect to any Option granted under this Plan, either concurrently with
the grant of such Option or at such later time as determined by the Administrator (as to all or any portion of the shares of Common
Stock subject to the Option), or (ii) alone, without reference to any related Option. Each SAR granted by the Administrator under
this Plan shall be subject to the following terms and conditions. Each SAR granted to any participant shall relate to such number
of shares of Common Stock as shall be determined by the Administrator, subject to adjustment as provided in Section 12. In the
case of an SAR granted with respect to an Option, the number of shares of Common Stock to which the SAR pertains shall be reduced
in the same proportion that the holder of the Option exercises the related Option. The exercise price of an SAR will be determined
by the Administrator, in its discretion, at the date of grant but may not be less than 100% of the Fair Market Value of the shares
of Common Stock subject thereto on the date of grant. Subject to the right of the Administrator to deliver cash in lieu of shares
of Common Stock (which, as it pertains to Officers and Directors of the Company, shall comply with all requirements of the Exchange
Act), the number of shares of Common Stock which shall be issuable upon the exercise of an SAR shall be determined by dividing:

 

    	 	9	 

     

    

 

(i)          the
number of shares of Common Stock as to which the SAR is exercised multiplied by the amount of the appreciation in such shares (for
this purpose, the “appreciation” shall be the amount by which the Fair Market Value of the shares of Common Stock subject
to the SAR on the exercise date exceeds (1) in the case of an SAR related to an Option, the exercise price of the shares of Common
Stock under the Option or (2) in the case of an SAR granted alone, without reference to a related Option, an amount which shall
be determined by the Administrator at the time of grant, subject to adjustment under Section 12); by

 

(ii)         the
Fair Market Value of a share of Common Stock on the exercise date.

 

In lieu of issuing shares of Common Stock upon the exercise
of an SAR, the Administrator may elect to pay the holder of the SAR cash equal to the Fair Market Value on the exercise date of
any or all of the shares which would otherwise be issuable. No fractional shares of Common Stock shall be issued upon the exercise
of an SAR; instead, the holder of the SAR shall be entitled to receive a cash adjustment equal to the same fraction of the Fair
Market Value of a share of Common Stock on the exercise date or to purchase the portion necessary to make a whole share at its
Fair Market Value on the date of exercise. The exercise of an SAR related to an Option shall be permitted only to the extent that
the Option is exercisable under Section 10 on the date of surrender.

 

(l)          Compliance
with Section 409A of the Code. Notwithstanding anything to the contrary set forth herein, any Award that is not exempt from
the requirements of Section 409A of the Code shall contain such provisions so that such Award will comply with the requirements
of Section 409A of the Code. Such restrictions, if any, shall be determined by the Administrator and contained in the Award Agreement
evidencing such Award.

 

(m)          Minimum
Vesting. Awards granted to Employees under the Plan that are subject to time vesting shall not vest or become exercisable until
at least one year after the date of grant, except in the case of death, Disability or a Corporate Transaction.

 

7.           Award
Exercise or Purchase Price, Consideration and Taxes.

 

(a)          Exercise
or Purchase Price. The exercise or purchase price, if any, for an Award shall be as follows.

 

(i)          In
the case of an Option, the per Share exercise price shall be not less than one-hundred percent (100%) of the Fair Market Value
per Share on the date of grant.

 

(ii)         In
the case of other Awards, such price as is determined by the Administrator.

 

(iii)        Notwithstanding
the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise
or purchase price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing the
agreement to issue such Award.

 

    	 	10	 

     

    

 

(b)          Consideration.
Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase of an Option or
upon the issuance of another Award, including the method of payment, shall be determined by the Administrator. In addition to any
other types of consideration the Administrator may determine, the Administrator is authorized to accept as consideration for Shares
issued under the Plan the following:

 

(i)          cash;

 

(ii)         check;

 

(iii)        delivery
of Grantee’s promissory note with such recourse, interest, security, and redemption provisions as the Administrator determines
as appropriate (but only to the extent that the acceptance or terms of the promissory note would not violate an Applicable Law);
provided, however, that interest shall compound at least annually and shall be charged at the minimum rate of interest necessary
to avoid (i) the imputation of interest income to the Company and compensation income to the Grantee under any applicable provisions
of the Code, and (B) the classification of the Award as a liability for financial accounting purposes;

 

(iv)        surrender
of Shares or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require which
have a Fair Market Value on the date of surrender or attestation equal to the aggregate exercise price of the Shares as to which
said Award shall be exercised;

 

(v)         payment
through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide written instructions to a
Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company
sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall provide written directives
to the Company to deliver the certificates (or other evidence satisfactory to the Company to the extent that the Shares are uncertificated)
for the purchased Shares directly to such brokerage firm in order to complete the sale transaction;

 

(vi)        with
respect to Options, payment through a “net exercise” such that, without the payment of any funds, the Grantee may exercise
the Option and receive the net number of Shares equal to (i) the number of Shares as to which the Option is being exercised,
multiplied by (ii) a fraction, the numerator of which is the Fair Market Value per Share (on such date as is determined by
the Administrator) less the Exercise Price per Share, and the denominator of which is such Fair Market Value per Share; or

 

(vii)       future
services to be rendered to the Company or a Related Entity; or

 

(viii)      any
combination of the foregoing methods of payment.

 

The Administrator may at any time or from time to time, by adoption
of or by amendment to the standard forms of Award Agreement described in Section 4(c)(iv), or by other means, grant Awards
which do not permit all of the foregoing forms of consideration to be used in payment for the Shares or which otherwise restrict
one or more forms of consideration.

 

    	 	11	 

     

    

 

8.            [Intentionally
Omitted].

 

9.            Withholding
of Additional Income Taxes.

 

(a)          Upon
the exercise of an Option or SAR, the grant of any other Award for less than the Fair Market Value of the Common Stock or the vesting
of restricted Common Stock acquired on the exercise of an Award hereunder, the Company, in accordance with Section 3402(a) of the
Code and any applicable state statute or regulation, may require the Grantee to pay to the Company additional withholding taxes
in respect of the amount that is considered compensation includable in such person’s gross income. With respect to (i) the
exercise of an Option, (ii) the grant of any other Award for less than its Fair Market Value, (iv) the vesting of restricted Common
Stock acquired by exercising an Award, or (v) the exercise of an SAR, the Committee in its discretion may condition such event
on the payment by the Grantee of any such additional withholding taxes.

 

(b)          At
the sole and absolute discretion of the Administrator, the holder of Awards may pay all or any part of the total estimated federal
and state income tax liability arising out of the exercise or receipt of such Awards or the vesting of restricted Common Stock
acquired on the exercise of an Award hereunder (each of the foregoing, a “Tax Event”) by tendering already-owned
shares of Common Stock or by directing the Company to withhold shares of Common Stock otherwise to be transferred to the Grantee
as a result of the exercise or receipt thereof in an amount equal to the estimated federal and state income tax liability arising
out of such event, provided that no more Shares may be withheld than are necessary to satisfy the Grantee’s actual minimum
withholding obligation with respect to the exercise of Awards unless excess share withholding would not result in liability accounting
treatment for Awards granted under the Plan under applicable accounting rules. In such event, the Grantee must, however, notify
the Administrator of his or her desire to pay all or any part of the total estimated federal and state income tax liability arising
out of a Tax Event by tendering already-owned shares of Common Stock or having shares of Common Stock withheld prior to the date
that the amount of federal or state income tax to be withheld is to be determined. For purposes of this Section 9, shares of Common
Stock shall be valued at their Fair Market Value on the date that the amount of the tax withholdings is to be determined.

 

10.           Exercise
of Award.

 

(a)          Procedure
for Exercise; Rights as a Stockholder.

 

(i)          Any
Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the
terms of the Plan and specified in the Award Agreement.

 

(ii)         An
Award shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the
terms of the Award by the person entitled to exercise the Award and full payment for the Shares with respect to which the Award
is exercised has been made, including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the
purchase price as provided in Section 7(b)(v).

 

    	 	12	 

     

    

 

(b)          Exercise
of Award Following Termination of Continuous Service. In the event of termination of a Grantee’s Continuous Service for
any reason other than Disability or death (but not in the event of a Grantee’s change of status from Employee to Consultant),
such Grantee may, but only during the Post-Termination Exercise Period (but in no event later than the expiration date of the term
of such Award as set forth in the Award Agreement), exercise the portion of the Grantee’s Award that was vested at the date
of such termination or such other portion of the Grantee’s Award as may be determined by the Administrator. The Grantee’s
Award Agreement may provide that upon the termination of the Grantee’s Continuous Service for Cause, the Grantee’s
right to exercise the Award shall terminate concurrently with the termination of Grantee’s Continuous Service. To the extent
that the Grantee’s Award was unvested at the date of termination, or if the Grantee does not exercise the vested portion
of the Grantee’s Award within the Post-Termination Exercise Period, the Award shall terminate.

 

(c)          Disability
of Grantee. In the event of termination of a Grantee’s Continuous Service as a result of his or her Disability, such
Grantee may, but only within twelve (12) months from the date of such termination (or such longer period as specified in the
Award Agreement but in no event later than the expiration date of the term of such Award as set forth in the Award Agreement),
exercise the portion of the Grantee’s Award that was vested at the date of such termination. To the extent that the Grantee’s
Award was unvested at the date of termination, or if Grantee does not exercise the vested portion of the Grantee’s Award
within the time specified herein, the Award shall terminate.

 

(d)          Death
of Grantee. In the event of a termination of the Grantee’s Continuous Service as a result of his or her death, or in
the event of the death of the Grantee during the Post-Termination Exercise Period or during the twelve (12) month period following
the Grantee’s termination of Continuous Service as a result of his or her Disability, the Grantee’s estate or a person
who acquired the right to exercise the Award by bequest or inheritance may exercise the portion of the Grantee’s Award that
was vested as of the date of termination, within twelve (12) months from the date of death (or such longer period as specified
in the Award Agreement but in no event later than the expiration of the term of such Award as set forth in the Award Agreement).
To the extent that, at the time of death, the Grantee’s Award was unvested, or if the Grantee’s estate or a person
who acquired the right to exercise the Award by bequest or inheritance does not exercise the vested portion of the Grantee’s
Award within the time specified herein, the Award shall terminate.

 

(e)          Extension
if Exercise Prevented by Law. Notwithstanding the foregoing, if the exercise of an Award within the applicable time periods
set forth in this Section 10 is prevented by the provisions of Section 11 below, the Award shall remain exercisable until
one (1) month after the date the Grantee is notified by the Company that the Award is exercisable, but in any event no later than
the expiration of the term of such Award as set forth in the Award Agreement.

 

11.         Conditions
Upon Issuance of Shares.

 

(a)          If
at any time the Administrator determines that the delivery of Shares pursuant to the exercise, vesting or any other provision of
an Award is or may be unlawful under Applicable Laws, the vesting or right to exercise an Award or to otherwise receive Shares
pursuant to the terms of an Award shall be suspended until the Administrator determines that such delivery is lawful and shall
be further subject to the approval of counsel for the Company with respect to such compliance. The Company shall have no obligation
to effect any registration or qualification of the Shares under federal or state laws.

 

    	 	13	 

     

    

 

(b)          As
a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the
time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or
distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws.

 

12.         Adjustments.
Subject to any required action by the stockholders of the Company, the number of Shares covered by each outstanding Award, and
the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or
which have been returned to the Plan, the exercise or purchase price of each such outstanding Award, as well as any other terms
that the Administrator determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in
the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification
of the Shares, or similar transaction affecting the Shares, (ii) any other increase or decrease in the number of issued Shares
effected without receipt of consideration by the Company, or (iii) any other transaction with respect to the Company’s
Common Stock including a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or
other distribution of stock or property), reorganization, liquidation (whether partial or complete) or any similar transaction;
provided, however that conversion of any convertible securities of the Company shall not be deemed to have been “effected
without receipt of consideration.” Such adjustment shall be made by the Administrator and its determination shall be final,
binding and conclusive. Except as the Administrator determines, no issuance by the Company of shares of stock of any class, or
securities convertible into shares of stock of any class, shall affect, and no adjustment by reason hereof shall be made with respect
to, the number or price of Shares subject to an Award. No adjustments shall be made for dividends paid in cash or in property other
than Common Stock of the Company, nor shall cash dividends or dividend equivalents accrue or be paid in respect of unexercised
Options or unvested Awards hereunder.

 

13.         Corporate
Transactions.

 

(a)          Termination
of Award to Extent Not Assumed in Corporate Transaction. Effective upon the consummation of a Corporate Transaction, all outstanding
Awards under the Plan shall terminate. However, all such Awards shall not terminate to the extent they are Assumed in connection
with the Corporate Transaction.

 

    	 	14	 

     

    

 

(b)          Acceleration
of Award Upon Corporate Transaction. The Administrator shall have the authority, exercisable either in advance of any actual
or anticipated Corporate Transaction or at the time of an actual Corporate Transaction and exercisable at the time of the grant
of an Award under the Plan or any time while an Award remains outstanding, to provide for the full or partial automatic vesting
and exercisability of one or more outstanding unvested Awards under the Plan and the release from restrictions on transfer and
repurchase or forfeiture rights of such Awards in connection with a Corporate Transaction on such terms and conditions as the Administrator
may specify. The Administrator also shall have the authority to condition any such Award vesting and exercisability or release
from such limitations upon the subsequent termination of the Continuous Service of the Grantee within a specified period following
the effective date of the Corporate Transaction. The Administrator may provide that any Awards so vested or released from such
limitations in connection with a Corporate Transaction shall remain fully exercisable until the expiration or sooner termination
of the Award.

 

14.          Effective
Date and Term of Plan. The Plan shall become effective upon the its adoption by the Board. It shall continue in effect for
a term of ten (10) years from the date of its adoption.

 

15.           Amendment,
Suspension or Termination of the Plan.

 

(a)          The
Board may at any time amend, suspend or terminate the Plan in any respect, except that it may not, without the approval of the
stockholders obtained within twelve (12) months before or after the Board adopts a resolution authorizing any of the following
actions, do any of the following:

 

(i)          increase
the total number of shares that may be issued under the Plan (except by adjustment pursuant to Section 12);

 

(ii)         the
provisions of Section 7(a) regarding the exercise price at which shares may be offered pursuant to Options may not be modified
(except by adjustment pursuant to Section 12);

 

(iii)        extend
the expiration date of the Plan; and

 

(iv)        except
as provided in Section 12 (including, without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization,
reorganization, merger, consolidation, split-up, spin-off, combination, or exchange of shares), the Company may not amend an Award
granted under the Plan to reduce its exercise price per share, cancel and regrant new Awards with lower prices per share than the
original prices per share of the cancelled Awards, or cancel any Awards in exchange for cash or the grant of replacement Awards
with an exercise price that is less than the exercise price of the original Awards, essentially having the effect of a repricing,
without approval by the Company’s stockholders.

 

(b)          No
Award may be granted during any suspension of the Plan or after termination of the Plan.

 

(c)          No
suspension or termination of the Plan (including termination of the Plan under Section 15, above) shall adversely affect any
rights under Awards already granted to a Grantee without his or her consent.

 

16.         Reservation
of Shares.

 

(a)          The
Company, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient
to satisfy the requirements of the Plan.

 

    	 	15	 

     

    

 

(b)          The
inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s
counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in
respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

 

17.         No
Effect on Terms of Employment/Consulting Relationship. The Plan shall not confer upon any Grantee any right with respect to
the Grantee’s Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or
a Related Entity to terminate the Grantee’s Continuous Service at any time, with or without Cause, and with or without notice.
The ability of the Company or any Related Entity to terminate the employment of a Grantee who is employed at will is in no way
affected by its determination that the Grantee’s Continuous Service has been terminated for Cause for the purposes of this
Plan.

 

18.         No
Effect on Retirement and Other Benefit Plans. Except as specifically provided in a retirement or other benefit plan of the
Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under
any retirement plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind
or any benefit plan subsequently instituted under which the availability or amount of benefits is related to level of compensation.
The Plan is not a “Retirement Plan” or “Welfare Plan” under the Employee Retirement Income Security Act
of 1974, as amended.

 

19.         Electronic
Delivery. The Administrator may, in its sole discretion, decide to deliver any documents related to any Award granted under
the Plan through an online or electronic system established and maintained by the Company or another third party designated by
the Company or to request a Grantee’s consent to participate in the Plan by electronic means. Each Grantee hereunder consents
to receive such documents by electronic delivery and agrees to participate in the Plan through an online or electronic system established
and maintained by the Company or another third party designated by the Company, and such consent shall remain in effect throughout
Grantee’s term of employment or service with the Company and any Related Entity and thereafter until withdrawn in writing
by Grantee.

 

20.         Data
Privacy. The Administrator may, in its sole discretion, decide to collect, use and transfer, in electronic or other form, personal
data as described in this Plan or any Award for the exclusive purpose of implementing, administering and managing participation
in the Plan. Each Grantee hereunder acknowledges that the Company holds certain personal information about Grantee, including,
but not limited to, name, home address and telephone number, date of birth, social security number or other identification number,
salary, nationality, job title, details of all Awards awarded, cancelled, exercised, vested or unvested, for the purpose of implementing,
administering and managing the Plan (the “Data”). Each Grantee hereunder further acknowledges that Data
may be transferred to any third parties assisting in the implementation, administration and management of the Plan and that these
third parties may be located in jurisdictions that may have different data privacy laws and protections, and Grantee authorizes
such third parties to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing,
administering and managing the Plan, including any requisite transfer of such Data as may be required to a broker or other third
party with whom the recipient or the Company may elect to deposit any shares of Common Stock acquired upon any Award.

 

    	 	16	 

     

    

 

21.         Compliance
with Section 409A. To the extent that the Administrator determines that any Award granted hereunder is subject to Section 409A
of the Code, the Award Agreement evidencing such Award shall incorporate the terms and conditions necessary to avoid the consequences
specified in Section 409A(a)(1) of the Code. To the extent applicable, the Plan and Award Agreements shall be interpreted in accordance
with Section 409A of the Code and Department of Treasury regulations and other interpretive guidance issued thereunder, including
without limitation any such regulations or other guidance that may be issued or amended after the effective date of the Plan. Notwithstanding
any provision of the Plan to the contrary, in the event that following the effective date of the Plan the Administrator determines
that any Award may be subject to Section 409A of the Code and related Department of Treasury guidance (including such Department
of Treasury guidance as may be issued after the effective date of the Plan), the Administrator may adopt such amendments to the
Plan and the applicable Award Agreement or adopt other policies and procedures (including amendments, policies and procedures with
retroactive effect), or take any other actions, that the Administrator determines are necessary or appropriate to (1) exempt the
Award from Section 409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to the Award,
or (2) comply with the requirements of Section 409A of the Code and related Department of Treasury guidance.

 

22.         Unfunded
Obligation. Grantees shall have the status of general unsecured creditors of the Company. Any amounts payable to Grantees pursuant
to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of the Employee
Retirement Income Security Act of 1974, as amended. Neither the Company nor any Related Entity shall be required to segregate any
monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The
Company shall retain at all times beneficial ownership of any investments, including trust investments, which the Company may make
to fulfill its payment obligations hereunder. Any investments or the creation or maintenance of any trust or any Grantee account
shall not create or constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and
a Grantee, or otherwise create any vested or beneficial interest in any Grantee or the Grantee’s creditors in any assets
of the Company or a Related Entity. The Grantees shall have no claim against the Company or any Related Entity for any changes
in the value of any assets that may be invested or reinvested by the Company with respect to the Plan.

 

23.         Construction.
Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision
of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include
the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

 

As approved by the Board
of Directors on April 3, 2017 

 

 

    	 	17Exhibit 10.2

 

ASSEMBLY BIOSCIENCES, INC.

2017 Inducement Award Plan

NOTICE OF STOCK OPTION GRANT

 

Grant Number 2017-

	 	 
	 	 
	 	 

 

You have been granted an option to purchase
Common Stock of Assembly Biosciences, Inc. (the "Company"), as follows:

 

	Date of Grant	[________]
	 	 
	Vesting Commencement Date	[_______]
	 	 
	Exercise Price per Share	$____
	 	 
	Total Number of Shares Granted	________
	 	 
	Total Exercise Price	$_______
	 	 
	Type of Option:	__________ Nonstatutory Stock Option
	 	 
	Term/Expiration Date:	10 years
	 	 
	Vesting Schedule:	[1/4 to vest on the first anniversary of the vesting commencement date; and thereafter 1/36 of remaining option shares (approximately _____ shares) to vest each month thereafter for 36 months; in each case subject to your Continuous Services through each vesting date and otherwise in accordance with the terms and conditions of the Plan (as defined below) and the Stock Option Agreement attached hereto. Shares to vest on any vesting date shall be rounded down to nearest whole number. Monthly installments shall take into effect prior rounding so that each monthly installment including the last installment is approximately the same. On the fourth anniversary of the vesting commencement date, the options shall be fully vested. Upon the occurrence of a Corporate Transaction and the termination of your employment by the Company other than for Cause within 6 months of such Corporate Transaction, all unvested options shall vest.]
	 	 
	Termination Period:	Option may be exercised for up to 90 days after termination of Continuous Service.  By your signature and the signature of the Company's representative below, you and the Company agree that this option is granted under and governed by the terms and conditions of the Assembly Biosciences, Inc. 2017 Inducement Award Plan (the “Plan”) and the Stock Option Agreement, all of which are attached and made a part of this document. Capitalized terms used in this Notice of Stock Option Grant and not otherwise defined herein shall have the meaning assigned to such term in the Plan.

 

	Dated:	 	 

 

	OPTIONEE:	 	ASSEMBLY BIOSCIENCES, INC.
	 	 	 
	 	 	By:	 
	[Name]	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	 	Title:	 

 

    	 	1	 

     

    

 

ASSEMBLY BIOSCIENCES, INC.

 

STOCK OPTION AGREEMENT

 

1.             Grant
of Option. Assembly Biosciences, Inc. (the "Company"), hereby grants to the Optionee named in the Notice of Grant
(the "Optionee") an option (the "Option") to purchase a total number of shares of Common Stock (the "Shares")
set forth in the Notice of Grant, at the exercise price per share set forth in the Notice of Grant (the "Exercise Price")
subject to the terms, definitions and provisions of the Assembly Biosciences, Inc. 2017 Inducement Award Plan (the "Plan")
adopted by the Company, which is incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan
shall have the same defined meanings in this Option.

 

2.             Exercise
of Option. This Option shall be exercisable during its term in accordance with the Vesting Schedule set out in the Notice of
Grant and with the provisions of Sections 10 and 11 of the Plan as follows:

 

(a)           Right
to Exercise.

 

(i)          This
Option may not be exercised for a fraction of a share.

 

(ii)         In
no event may this Option be exercised after the date of expiration of the term of this Option as set forth in the Notice of Grant.

 

(b)          Method
of Exercise. This Option shall be exercisable by written notice (in the form attached hereto as Exhibit A) which
shall state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised, and such
other representations and agreements as to the holder's investment intent with respect to such shares of Common Stock as may be
required by the Company pursuant to the provisions of the Plan. Such written notice shall be signed by the Optionee and shall be
delivered in person, by certified mail or by electronic mail (with confirmation of receipt) to the Secretary of the Company. The
written notice shall be accompanied by payment of the Exercise Price. This Option shall be deemed to be exercised upon receipt
by the Company of such written notice accompanied by the Exercise Price.

 

Notwithstanding anything to the contrary contained
herein, you may not exercise your option unless the shares of Common Stock issuable upon such exercise are then registered under
the Securities Act of 1933, as amended (the “Securities Act”), or, if such shares of Common Stock are not then so registered,
the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities
Act. The exercise of your option also must comply with other applicable laws and regulations governing your option, and you may
not exercise your option if the Company determines that such exercise would not be in material compliance with such laws and regulations.
No Shares will be issued pursuant to the exercise of an Option unless such issuance and such exercise shall comply with all relevant
provisions of law and the requirements of any stock exchange upon which the Shares may then be listed. Assuming such compliance,
for income tax purposes the Shares shall be considered transferred to the Optionee on the date on which the Option is exercised
with respect to such Shares.

 

    	 	2	 

     

    

 

3.            Method
of Payment. Payment of the Exercise Price shall be by any of the following, or a combination thereof, at the election of the
Optionee:

(i)           cash;
or

 

(ii)          check;
or

 

(iii)         surrender
of other shares of Common Stock of the Company, or attestation of ownership of such shares, as described in Section 7(b)(iv) of
the Plan; or

 

(iv)        “net
exercise” as described in Section 7(b)(vi) of the Plan; or

 

(v)          a
broker-assisted exercise as described in Section 7(b)(v) of the Plan; or

 

(vi)         promissory
note as described in Section 7(b)(iii) of the Plan to the extent not prohibited by applicable law; or

 

(vii)        any
combination of the foregoing methods of payment.

 

4.            Nontransferability
of Option. This Option may not be transferred in any manner other than as set forth in the Plan. The terms of this Option shall
be binding upon the executors, administrators, heirs, successors transferees and assigns of the Optionee as if such persons were
the Optionee.

 

5.            Termination
of Relationship. In the event of termination of Optionee's employment or consulting relationship with the Company, Optionee
may, to the extent otherwise so entitled at the date of such termination (the "Termination Date"), exercise this Option
during the Termination Period set out in the Notice of Grant. To the extent that Optionee was not entitled to exercise this Option
at the date of such termination, or if Optionee does not exercise this Option within the time specified herein, the Option shall
terminate.

 

6.            Term
of Option. This Option may be exercised only within the term set out in the Notice of Grant and the Plan, and may be exercised
during such term only in accordance with the Plan and the terms of this Option.

 

7.            Disability
of Optionee. Notwithstanding the provisions of Section 5 above, in the event of termination of Optionee's consulting or employment
relationship as a result of his total and permanent disability (as defined in Section 22(e)(3) of the Code or any successor provision),
Optionee may, but only within twelve (12) months from the date of termination of employment or consulting relationship (but in
no event later than the date of expiration of the term of this Option as set forth in the Notice of Grant), exercise this Option
to the extent Optionee was entitled to exercise it at the date of such termination. To the extent that Optionee was not entitled
to exercise the Option at the date of termination, or if Optionee does not exercise such Option (which Optionee was entitled to
exercise) within the time specified herein, the Option shall terminate.

 

    	 	3	 

     

    

 

8.            Death
of Optionee. In the event of the death of Optionee during the term of this Option and, with respect to a consultant, during
such consultant’s continuing consulting relationship with the Company or within 90 days of termination of consultant's relationship
with the Company and, with respect to an employee, during such employee’s employment relationship with the Company or within
90 days of termination of such employee's relationship with the Company, the Option may be exercised at any time within twelve
(12) months following the date of termination (but in no event later than the date of expiration of the term of this Option as
set forth in the Notice of Grant), by Optionee's estate or by a person who acquired the right to exercise the Option by bequest
or inheritance, but only to the extent of the right to exercise that Optionee was entitled to at the date of death.

 

9.            Taxation
Upon Exercise of Option. Pursuant to Section 9 of the Plan, the Company may require the Optionee to pay to the Company amounts
necessary to satisfy any applicable Company withholding obligations. The Optionee shall satisfy his or her tax withholding obligation
arising upon the exercise of this Option by one or some combination of the following methods: (i) by cash payment, or (ii) out
of Optionee's current compensation, or (iii) if permitted by the Board or Committee, in its discretion, by surrendering to the
Company already-owned Shares or by directing the Company to withhold shares otherwise to be transferred to the Optionee, in each
case in accordance with Section 9(b) of the Plan. For this purpose, the fair market value of the Shares to be withheld shall be
determined on the date that the amount of tax to be withheld is to be determined (the "Tax Date").

 

If the Optionee is subject to Section 16
of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (an "Insider"), any surrender of previously
owned Shares to satisfy tax withholding obligations arising upon exercise of this Option must comply with the applicable provisions
of Rule 16b-3 promulgated under the Exchange Act ("Rule 16b-3") and shall be subject to such additional conditions or
restrictions as may be required thereunder to qualify for the maximum exemption from Section 16 of the Exchange Act with respect
to Plan transactions.

 

All elections by an Optionee to have Shares
withheld to satisfy tax-withholding obligations shall be made in writing in a form acceptable to the Committee and shall be subject
to the following restrictions:

 

(1)         the
election must be made on or prior to the applicable Tax Date;

 

(2)         once
made, the election shall be irrevocable as to the particular Shares of the Option as to which the election is made;

 

(3)         all
elections shall be subject to the consent or disapproval of the Board or Committee;

 

(4)         if
the Optionee is an Insider, the election must comply with the applicable provisions of Rule 16b-3 and shall be subject to such
additional conditions or restrictions as may be required thereunder to qualify for the maximum exemption from Section 16 of the
Exchange Act with respect to Plan transactions.

 

    	 	4	 

     

    

 

10.           Tax
Consequences. Set forth below is a brief summary as of the date of this Option of some of the federal tax consequences of exercise
of this Option and disposition of the Shares. THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT
TO CHANGE. OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.

 

(a)            Exercise
of Nonstatutory Stock Option. There may be a regular federal income tax liability and a state income tax liability upon the
exercise of the Option. The Optionee will be treated as having received compensation income (taxable at ordinary income tax rates)
equal to the excess, if any, of the fair market value of the Shares on the date of exercise over the Exercise Price and the Company
will qualify for a deduction in the same amount, subject to the requirement that the compensation be reasonable. If Optionee is
an employee, the Company will be required to withhold from Optionee's compensation or collect from Optionee and pay to the applicable
taxing authorities an amount equal to a percentage of this compensation income at the time of exercise.

 

(b)          Disposition
of Shares. If Shares are held for at least one year, any gain realized on disposition of the Shares will be treated as long-term
capital gain for federal income tax purposes.

 

11.           Successors
and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement
shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth,
this Agreement shall be binding upon Optionee and his or her heirs, executors, administrators, successors, transferees and assigns.

 

12.           Interpretation.
Any dispute regarding the interpretation of this Agreement shall be submitted by Optionee or by the Company forthwith to the Company's
Board of Directors or the Committee that administers the Plan, which shall review such dispute at its next regular meeting. The
resolution of such a dispute by the Board or committee shall be final and binding on the Company and on Optionee.

 

13.           Governing
Law; Severability. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware excluding
that body of law pertaining to conflicts of law. Should any provision of this Agreement be determined by a court of law to be illegal
or unenforceable, the other provisions shall nevertheless remain effective and shall remain enforceable.

 

14.           Notices.
Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon receipt or three
(3) days after deposit in the United States mail by certified mail, with postage and fees prepaid, addressed to in the case of
the Company at its corporate headquarters and in the case of Optionee at the last address Optionee provided to the Company. Notwithstanding
the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and
this option by electronic means or to request your consent to participate in the Plan by electronic means. You hereby consent to
receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic
system established and maintained by the Company or another third party designated by the Company.

 

    	 	5	 

     

    

 

15.           Option
Not a Service Contract.

 

(a)            Your
Continuous Service with the Company or a Related Entity is not for any specified term and may be terminated by you or by the Company
or a Related Entity at any time, for any reason, with or without cause and with or without notice. Nothing in this Agreement (including,
but not limited to, the vesting of your Option pursuant to the schedule set forth in the Notice of Stock Option Grant or the issuance
of the shares upon exercise of your option), the Plan or any covenant of good faith and fair dealing that may be found implicit
in this Agreement or the Plan shall: (i) confer upon you any right to continue in the employ of, or affiliation with, the Company
or a Related Entity; (ii) constitute any promise or commitment by the Company or a Related Entity regarding the fact or nature
of future positions, future work assignments, future compensation or any other term or condition of employment or affiliation;
(iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically accrued under
the terms of this Agreement or Plan; or (iv) deprive the Company of the right to terminate you at will and without regard to any
future vesting opportunity that you may have.

 

(b)           By accepting this Option, you acknowledge
and agree that the right to continue vesting in the Option pursuant to the schedule set forth in Notice of Stock Option Grant is
earned only by continuing as an employee, director or consultant at the will of the Company (not through the act of being hired,
being granted this option or any other award or benefit) and that the Company has the right to reorganize, sell, spin-out or otherwise
restructure one or more of its businesses or Related Entity at any time or from time to time, as it deems appropriate (a “reorganization”).
You further acknowledge and agree that such a reorganization could result in the termination of your Continuous Service, or the
termination of Related Entity status of your employer and the loss of benefits available to you under this Agreement, including
but not limited to, the termination of the right to continue vesting in the option. You further acknowledge and agree that this
Agreement, the Plan, the transactions contemplated hereunder and the vesting schedule set forth herein or any covenant of good
faith and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement
as an employee or consultant for the term of this Agreement, for any period, or at all, and shall not interfere in any way with
your right or the Company’s right to terminate your Continuous Service at any time, with or without Cause and with or without
notice.

 

16.           Further
Instruments. The parties agree to execute such further instruments and to take such further action as may be reasonably necessary
to carry out the purposes and intent of this Agreement.

 

17.           2017
Inducement Award Plan. This Option shall be subject to and governed by the terms and conditions of the Plan in all respects,
and to the extent of any inconsistency between this Option and the terms of the Plan, the terms of the Plan will control. Optionee
acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and
hereby accepts this Option subject to all of the terms and provisions thereof. Optionee has reviewed the Plan and this Option in
their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option and fully understands all
provisions of the Option. Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of
the Board or Committee upon any questions arising under the Plan or this Option.

 

18.           Other
Documents. You acknowledge receipt of the Company’s insider trading policy and agree to comply with its terms.

 

 

    	 	6	 

     

    

 

EXHIBIT A

 

ASSEMBLY BIOSCIENCES, INC.

 

EXERCISE NOTICE

	 	 
	Assembly Biosciences, Inc.	 
	 	 
	 	 
	Attention:  Secretary	 

 

1.          Exercise
of Option. Effective as of today, the undersigned ("Optionee") hereby elects to exercise Optionee's option to purchase
_____________ shares of the Common Stock (the "Shares") of Assembly Biosciences, Inc. (the "Company") under
and pursuant to the Company's 2017 Inducement Award Plan (as amended from time to time, the "Plan") and the Notice of
Stock Option Grant dated __________, 20___ with its attached Stock Option Agreement (the "Option Agreement"). The purchase
price for the Shares shall be $__________ as required by the Option Agreement. Optionee herewith delivers to the Company the full
Exercise Price for the Shares.

 

2.          Representations
of Optionee. Optionee acknowledges that Optionee has received, read and understood the Plan and the Option Agreement and agrees
to abide by and be bound by their terms and conditions. Optionee represents that Optionee is purchasing the Shares for Optionee's
own account for investment and not with a view to, or for sale in connection with, a distribution of any of such Shares.

 

3.          Rights
as Stockholder. Until the stock certificate evidencing such Shares is issued (as evidenced by the appropriate entry on the
books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other
rights as a stockholder shall exist with respect to the optioned Shares, notwithstanding the exercise of the Option. The Company
shall issue (or cause to be issued) such stock certificate promptly after the Option is exercised.

 

4.          Tax
Consultation. Optionee understands that Optionee may suffer adverse tax consequences as a result of Optionee's purchase or
disposition of the Shares. Optionee represents that Optionee has consulted with any tax consultants Optionee deems advisable in
connection with the purchase or disposition of the Shares and that Optionee is not relying on the Company for any tax advice.

 

5.          Entire
Agreement. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Option
Agreement and any Investment Representation statement executed and delivered to Company by Optionee shall constitute the entire
agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with
respect to the subject matter hereof, and is governed by Delaware law except for that body of law pertaining to conflict of laws.

 

     

     

    

 

 

	Submitted by:	 	 Accepted by:
	 	 	 
	OPTIONEE:	 	Assembly Biosciences, Inc.
	 	 	 
	 	 	By:	 
	 	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	 	Title:	 
	 	 	 	 
	Address:	 	 	 Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]